Thrombosis, or blood clots as they are colloquially known, tend to manifest naturally in men more than women. Women, however, are at risk for blood clots primarily because of pregnancy, birth control, and other hormonal therapies men do not generally take, according to StopTheClot.org.
Sometimes prominent drugs are recalled and no one knows about it. This was the case with a 2010 Food and Drug Administration (FDA) recall of the birth control Yaz, a contraceptive approved by the FDA for use among women as young as 14 years old. Yaz and Beyaz—a similar FDA-approved medication made by the same manufacturer, Berlex, Inc.—hit the market when it was approved in 2006, according to Drugs.com.
This April, a batch of ParaGard T 380A Intrauterine Copper Contraceptive devices were recalled due to a lack of assurance of sterility, according to the Food and Drug Administration (FDA). The device’s parent company, TEVA Pharmaceuticals which is based in Pennsylvania, voluntarily recalled the devices from hospitals, clinics, and gynecologists across the country.
According to Fox News, more than 3,600 women have joined together to file an unsafe medical drug lawsuit against drug manufacturer Merck. According to the lawsuit, more than 100 women have died as a result of using the company’s contraceptive, NuvaRing.
Lawyers associated with the suit argue that the contraceptive ring caused blood clots that resulted in death. They also state that Merck failed to include the risk of clots on the medication label and did not inform doctors that NuvaRing carries a clotting risk that is up to five times greater than traditional birth control pills.